These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2245439)

  • 1. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
    Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
    Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
    Silvestrini R; Daidone MG; Valagussa P; Di Fronzo G; Mezzanotte G; Mariani L; Bonadonna G
    J Clin Oncol; 1990 Aug; 8(8):1321-6. PubMed ID: 2380758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterisation of primary and metachronous lesions in breast cancer patients.
    Silvestrini R; Valentinis B; Daidone MG; Di Fronzo G; Coradini D; Salvadori B
    Eur J Cancer; 1992; 28A(12):2006-10. PubMed ID: 1419299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects.
    Paradiso A; Mangia A; Barletta A; Fusilli S; Marzullo F; Schittulli F; De Lena M
    Eur J Cancer; 1995 Jun; 31A(6):911-6. PubMed ID: 7646920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell kinetics and hormonal features in relation to pathological stage in breast cancer.
    Amadori D; Bonaguri C; Nanni O; Gentilini P; Lundi N; Zoli W; Riccobon A; Vio A; Magni E; Saragoni A
    Breast Cancer Res Treat; 1991 Mar; 18(1):19-25. PubMed ID: 1854976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers.
    Collecchi P; Baldini E; Giannessi P; Naccarato AG; Passoni A; Gardin G; Roncella M; Evangelista G; Bevilacqua G; Conte PF
    Eur J Cancer; 1998 Oct; 34(11):1701-4. PubMed ID: 9893655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.
    Silvestrini R; Daidone MG; Mastore M; Di Fronzo G; Coradini D; Boracchi P; Squicciarini P; Salvadori B; Veronesi U
    J Clin Oncol; 1993 Jun; 11(6):1150-5. PubMed ID: 8501501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cell kinetics induced by primary chemotherapy in breast cancer.
    Daidone MG; Silvestrini R; Valentinis B; Ferrari L; Bartoli C
    Int J Cancer; 1991 Feb; 47(3):380-3. PubMed ID: 1993544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the thymidine labeling and Ki-67 proliferative indices in 126 breast cancer patients.
    Molino A; Pedersini R; Micciolo R; Frisinghelli M; Giovannini M; Pavarana M; Nortilli R; Santo A; Manno P; Padovani M; Piubello Q; Cetto GL
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):304-9. PubMed ID: 12607597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological correlation between HER-2/neu and proliferative activity in human breast cancer.
    Tommasi S; Paradiso A; Mangia A; Barletta A; Simone G; Slamon DJ; De Lena M
    Anticancer Res; 1991; 11(4):1395-400. PubMed ID: 1684096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine labeling index in breast tumors.
    Lee HD; Soh EY; Chi HS; Kim BR; Lee KS; Song KS; Jung HJ
    Jpn J Surg; 1990 Mar; 20(2):180-5. PubMed ID: 1692890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
    Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
    J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kinetics: an independent prognostic variable in stage II melanoma of the skin.
    Costa A; Silvestrini R; Mezzanotte G; Vaglini M; Grignolio E; Clemente C; Cascinelli N
    Br J Cancer; 1990 Nov; 62(5):826-9. PubMed ID: 2245175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of the labelling index in tumour studies.
    Hamilton E; Dobbin J
    Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term prognostic significance of the thymidine labelling index in breast cancer.
    Tubiana M; Pejovic MH; Chavaudra N; Contesso G; Malaise EP
    Int J Cancer; 1984 Apr; 33(4):441-5. PubMed ID: 6706431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.
    Galietta A; Pizzi C; Pettinato G; Limite G; Sgambato A; Lamberti M; Muraro R; Formisano C; Pensabene M; Bianco AR; Mariani-Costantini R; Contegiacomo A
    Oncol Rep; 2002; 9(1):135-40. PubMed ID: 11748471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA labelling index: a prognostic factor in node-negative breast cancer.
    Héry M; Gioanni J; Lalanne CM; Namer M; Courdi A
    Breast Cancer Res Treat; 1987; 9(3):207-11. PubMed ID: 3663956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.